Is serum protein electrophoresis (SPEP) the same as flow cytometry?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

No, SPEP and Flow Cytometry Are Completely Different Laboratory Tests

Serum protein electrophoresis (SPEP) and flow cytometry are fundamentally distinct laboratory techniques that measure different things using different methodologies—they are not the same and serve complementary but separate roles in the evaluation of plasma cell disorders.

What Each Test Actually Measures

SPEP (Serum Protein Electrophoresis)

  • Separates serum proteins based on their electrical charge and size
  • Detects monoclonal proteins (M-proteins) as abnormal peaks or bands in the gamma region
  • Quantifies protein fractions: albumin, alpha-1, alpha-2, beta, and gamma globulins
  • Performed on serum samples using electrophoresis methodology
  • Shows the product of abnormal plasma cells (the immunoglobulin they secrete into blood)

Flow Cytometry

  • Analyzes individual cells using fluorescent antibodies against cell surface markers
  • Identifies and enumerates plasma cells directly in bone marrow or blood samples
  • Determines immunophenotype of plasma cells (CD38, CD138, CD45, CD19, CD56, etc.)
  • Assesses clonality by detecting kappa/lambda light chain restriction on cell surfaces 1
  • Shows the cells themselves that are producing abnormal protein

Why Both Tests Matter in Plasma Cell Disorders

The European Myeloma Network guidelines clearly distinguish these as separate diagnostic tools 1:

Flow Cytometry Applications:

  • Differential diagnosis between neoplastic plasma cell disorders and reactive plasmacytosis
  • Enumeration of plasma cells as percentage of bone marrow cells
  • Detection of abnormal immunophenotype (e.g., CD19-negative, CD56-positive patterns)
  • Minimal residual disease monitoring after treatment with high sensitivity
  • Prognostic assessment based on abnormal vs. normal plasma cell ratios

SPEP Applications:

  • Initial screening for monoclonal gammopathies
  • Quantification of M-protein levels for disease monitoring
  • Classification of immunoglobulin type (IgG, IgA, IgM)
  • Response assessment by tracking M-protein reduction

Clinical Context: When to Use Each

According to consensus recommendations 2:

Standard myeloma workup requires BOTH:

  • SPEP with immunofixation on serum
  • 24-hour urine protein electrophoresis with immunofixation
  • Bone marrow aspirate/biopsy with morphologic assessment
  • Flow cytometry is recommended but not universally standardized 2

Key distinction: You can have an abnormal SPEP (M-protein in blood) without doing flow cytometry, and you can perform flow cytometry on bone marrow to characterize plasma cells without having done SPEP. They provide different, complementary information.

Common Pitfall to Avoid

Do not assume that detecting a monoclonal protein by SPEP tells you about the immunophenotype or clonality of bone marrow plasma cells—this requires flow cytometry 1. Conversely, flow cytometry on bone marrow does not quantify circulating M-protein levels, which requires SPEP.

Recent data 3 confirms that flow cytometry light chain assessment correlates with serum free light chain assays but represents a distinct methodology examining cellular rather than serum protein characteristics.

References

Related Questions

What does an elevated erythrocyte sedimentation rate and C‑reactive protein together with increased serum free light chains and an abnormal kappa‑to‑lambda ratio indicate, and how should it be evaluated?
In a multiple myeloma patient 6 months after autologous stem cell transplantation, bone marrow flow cytometry shows approximately 0.5% clonal plasma cells. Does this indicate relapse or is it an expected finding?
What does a negative immune electrophoresis with an elevated kappa/lambda ratio and elevated free kappa light chains indicate, and how should it be managed?
What is the clinical significance of a kappa‑to‑lambda free light‑chain ratio of 0.08 and what diagnostic work‑up should be performed?
In an 87‑year‑old patient with an isolated elevation of serum free kappa light chain (initially 28.6 mg/L, decreasing to 23.4 mg/L on repeat) and normal serum protein electrophoresis, urine protein electrophoresis, and lambda light chains, what is the most likely diagnosis and how should this be managed?
Is there a single oral appliance that can treat both obstructive sleep apnea and sleep-related bruxism?
In a woman with an elevated HbA1c who was started on metformin 500 mg daily one week ago and the dose was increased to 1000 mg daily today, what are the next steps in management?
What is the appropriate intramuscular dexamethasone dose for a child weighing 16.42 kg?
Does pembrolizumab cause an increase in serum creatinine?
What is the strength (units per gram) of Nystatin powder and the appropriate dosage regimens for oral thrush and vaginal candidiasis?
Can you interpret the chest imaging of a breastfeeding patient with a likely viral upper respiratory infection presenting with cough?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.